We are a non-profit organization committed to fostering hope and enhancing the lives of cardiovascular disease patients of all ages, their families, and caregivers.
Through ongoing peer-to-peer support, patient education, and advocacy, our mission is to build a community characterized by resilience, care, and collective strength in overcoming challenges.
Join us in shaping a world where every cardiovascular disease patient has access to the resources and support needed to live a healthy life.
At Mended Hearts Europe, we recognise that informed decisions are pivotal in healthcare, and our commitment lies in equipping cardiovascular disease patients and their loved ones with the knowledge needed to make sound choices, ultimately enhancing their quality of life.
Explore the latest resources for heart health and recovery.
Also available in: German (CH), Dutch (BE), French (FR), French (FR), Spanish,
Also available in: Dutch (BE), French (BE), French (FR), German (CH), Spanish,
Also available in: Dutch (BE), French (BE), French, German (CH), Spanish,
Also available in: Dutch (BE), French (BE), French (FR), German (CH), Spanish,
Also available in: Flemish, French, German (CH), Spanish,
Also available in: English (IE), Dutch (BE), French (BE), German, Spanish,
Also available in: Dutch (BE), French (BE), German,
Also available in: German, French (BE), Dutch (BE), English (IE), Spanish,
Stay up to date with the latest updates and stories
Key Takeaways from the Cardio-Kidney-Metabolic Policy Forum
25 June 2026 | By Mended Hearts Europe
Across the global pharmaceutical landscape, a profound shift in pricing mechanisms is reshaping how – and when – new treatments reach European patients. At the center of this shift is the United States’ adoption of Most Favoured Nation (MFN) and international reference pricing benchmarks, which tie domestic public drug reimbursement to the lowest prices paid across comparable OECD nations.
28 September 2026 | By Mended Hearts Europe
Your donations help us support more people living with cardiovascular conditions.
